Drugs / perflutren protein type A
perflutren protein type A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02321527 | Jul 2015 → May 2016 | breast cancer | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | perflutren protein type A | “you will receive perflutren protein type A by injection under the skin near the nipple” NCT02321527 ↗ |
| Modality | Diagnostic / imaging agent | “an ultrasound contrast agent called OPTISON (perflutren protein type A) is effective in finding sentinel lymph nodes before surgery” NCT02321527 ↗ |
| Route | Subcutaneous | “by injection under the skin near the nipple” NCT02321527 ↗ |